BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33388881)

  • 21. Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
    Hu Y; Yang C; Shen G; Yang S; Cheng X; Cheng F; Rao J; Wang X
    Liver Transpl; 2019 Jul; 25(7):1074-1090. PubMed ID: 30972941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Sphingosine Kinase 1 Attenuates Sepsis-induced Microvascular Leakage via Inhibiting Macrophage NLRP3 Inflammasome Activation in Mice.
    Zhong M; Wu W; Wang Y; Mao H; Song J; Chen S; Zhu D
    Anesthesiology; 2020 Jun; 132(6):1503-1515. PubMed ID: 32108663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate.
    Kim YM; Lim SC; Han CY; Kay HY; Cho IJ; Ki SH; Lee MY; Kwon HM; Lee CH; Kim SG
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):861-9. PubMed ID: 21212405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation.
    Son S; Shim DW; Hwang I; Park JH; Yu JW
    Front Immunol; 2019; 10():1108. PubMed ID: 31156650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.
    Doyle TM; Chen Z; Durante M; Salvemini D
    J Pain; 2019 Aug; 20(8):956-964. PubMed ID: 30802544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J; Yuan Z; Wang G; Wang X; Li K
    Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.
    Choi J; Cho Y; Choi H; Lee S; Han H; Lee J; Kwon J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
    Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
    Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis.
    Tian J; Chang S; Wang J; Chen J; Xu H; Huang T; Wang J; Kang J; Fan W; Wang Y
    Mol Immunol; 2023 Aug; 160():55-66. PubMed ID: 37379683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release.
    Zhao S; Gong Z; Du X; Tian C; Wang L; Zhou J; Xu C; Chen Y; Cai W; Wu J
    J Immunol Res; 2018; 2018():2481418. PubMed ID: 29854830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice.
    Wen T; Xie J; Ma L; Hao Z; Zhang W; Wu T; Li L
    Am J Pathol; 2024 Mar; 194(3):369-383. PubMed ID: 38104651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-sensing receptor activates the NLRP3 inflammasome in LS14 preadipocytes mediated by ERK1/2 signaling.
    D'Espessailles A; Mora YA; Fuentes C; Cifuentes M
    J Cell Physiol; 2018 Aug; 233(8):6232-6240. PubMed ID: 29345311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2Y1 Receptor Signaling Contributes to High Salt-Induced Priming of the NLRP3 Inflammasome in Retinal Pigment Epithelial Cells.
    Prager P; Hollborn M; Steffen A; Wiedemann P; Kohen L; Bringmann A
    PLoS One; 2016; 11(10):e0165653. PubMed ID: 27788256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes
    Gritsenko A; Yu S; Martin-Sanchez F; Diaz-Del-Olmo I; Nichols EM; Davis DM; Brough D; Lopez-Castejon G
    Front Immunol; 2020; 11():565924. PubMed ID: 33101286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galpha12 specifically regulates COX-2 induction by sphingosine 1-phosphate. Role for JNK-dependent ubiquitination and degradation of IkappaBalpha.
    Ki SH; Choi MJ; Lee CH; Kim SG
    J Biol Chem; 2007 Jan; 282(3):1938-47. PubMed ID: 17098744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxynitrite/PKR Axis Modulates the NLRP3 Inflammasome of Cardiac Fibroblasts.
    Lan T; Tao A; Xu X; Kvietys P; Rui T
    Front Immunol; 2020; 11():558712. PubMed ID: 33101273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
    Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
    J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy.
    Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M
    Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sphingosine signaling dysfunction in airway cells as a potential contributor to progression from protracted bacterial bronchitis to bronchiectasis in children.
    Hodge S; Macowan M; Liu H; Hamon R; Chen AC; Marchant JM; Pizzutto SJ; Upham JW; Chang AB
    Pediatr Pulmonol; 2020 Jun; 55(6):1414-1423. PubMed ID: 32176839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chicken cathelicidin-2 promotes IL-1β secretion via the NLRP3 inflammasome pathway and serine proteases activity in LPS-primed murine neutrophils.
    Peng L; Lu Y; Tian H; Jia K; Tao Q; Li G; Wan C; Ye C; Veldhuizen EJA; Chen H; Fang R
    Dev Comp Immunol; 2022 Jun; 131():104377. PubMed ID: 35189160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.